Main Session
Sep 30
SS 37 - Head and Neck 4: Refining Radiation: What Clinical Trials Can Tell Us

316 - High Bleeding Rates in a Randomized Phase 2 Trial of SBRT with Concurrent and Adjuvant Cetuximab +/- Docetaxel in Previously-Irradiated HNSCC

01:25pm - 01:35pm PT

Presenter(s)

Alberto Vera, MD - UPMC Cancer Center, Pittsburgh, PA